Michela Pivetta

Using Soluble CD38 to Overcome Daratumumab Interference in Pretransfusion Compatibility Testing

Michela Pivetta & Gianluca Gessoni · International Blood Research & Reviews · 2024

Background: CD38 is a protein highly expressed on myeloma (MM) cells that has been shown to be an effective target antigen for monoclonal antibody therapies, so treatment with anti-CD38 monoclonal antibodies is a first line therapy for patients with MM. Although CD38 is weaker ex...

Open access Research Article 10.9734/ibrr/2024/v15i3343

Convalescent Plasma Infusion does not Appear to Change the Prognosis in Italian Patients Hospitalized with Sars-Cov-2 Pneumonia

Gianluca Gessoni, Giovanni Roveroni, Lauretta Moro, Michela Pivetta, Michele Tessarin, Domenico Bagnara, Sara Valverde, Rossi Carla, Coluccia Enza, Collodel Luca, Roberto Valle & Giovanni Carretta · International Blood Research & Reviews · 2023

Aims: This case-control prospective study aimed to describe the effects of COVID convalescent plasma (CCP) on late mortality in hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia.  Study Design: In this study were enrolled 214 consecutive patients with moder...

Open access Research Article 10.9734/ibrr/2023/v14i2305

Convalescent Plasma Infusion in Italian Hospitalized Patients with Severe COVID 19 Pneumonia: Evaluation of Late Mortality Associated Factors

Gianluca Gessoni, Giovanni Roveroni, Lauretta Moro, Michela Pivetta, Michele Tessarin, Domenico Bagnara, Sara Valverde, Rossi Carla, Coluccia Enza, Collodel Luca, Roberto Valle & Giovanni Carretta · International Blood Research & Reviews · 2023

Background: This was a single center prospective study about factors related with mortality in hospitalized patients with severe COVID-19 pneumonia treated with convalescent plasma (CCP) infusion in Venice Prefecture. Methods: In this study were enrolled all the (376) consecutive...

Open access Research Article 10.9734/ibrr/2023/v14i2302

Integrated Clinical, Respiratory and Biomarker Prediction of Mortality in Patients with Severe COVID-19 Pneumonia Treated with Convalescent Plasma: Development and Internal Validation of Prognostic Models

Gianluca Gessoni, Sara Valverde, Francesca Gessoni, Giovanni Roveroni, Lauretta Moro, Carla Rossi, Giulia de Fusco, Enza Coluccia, Gianni Tidore, Luca Collodel, Rosaria Piatti, Federica Mazzetto, Gabriella Mazzaro, Michela Pivetta, Cecilia Callari & Silvia da Ros · Asian Journal of Research in Infectious Diseases · 2026

Background: Mortality risk among patients with severe COVID-19 is determined by interacting clinical, respiratory and systemic factors. This study evaluated whether routinely available respiratory and biomarker information could provide incremental prognostic information in a coh...

Open access Research Article 10.9734/ajrid/2026/v17i10595